Image 1 of 4
Image 2 of 4
Image 3 of 4
Image 4 of 4
Packaging & supply options
Your format, your way.
The same research peptide, with a choice of accessories and supply formats. Here’s what each option includes.
BAC water
Vial kit
Lyophilised peptide vial with separately packaged, complimentary BAC water.
BAC water + syringes
Syringe kit
Lyophilised peptide vial, BAC water and syringes.
BAC water + pen
Injection pen kit
Lyophilised peptide vial, BAC water and an injection pen.
Pen + pen needles
Reconstituted pen
VIETNAM ONLYPeptide solution supplied in a pen at the stated concentration, with pen needles.
For laboratory research only. Not for human or veterinary use.
Everform Pharma · Compound profile
Ipamorelin.
Understanding the response.
Explore growth hormone signalling, ghrelin-receptor biology and what the published research actually measures.
What is Ipamorelin?
Ipamorelin is a synthetic pentapeptide: a molecule built from five amino-acid residues. It belongs to the growth hormone secretagogue family, a group investigated for stimulating the release of growth hormone rather than supplying growth hormone itself. [1]
Its scientific profile spans endocrine signalling and gastrointestinal motility. Researchers have examined its activity in cell preparations, animal experiments and human studies, with different questions and outcomes in each setting. [1] [2] [3]
How it works
Ipamorelin acts as an agonist at the ghrelin receptor, also called the growth hormone secretagogue receptor. This signalling system is distinct from the GHRH receptor targeted by GHRH analogues. Ghrelin-receptor activity connects Ipamorelin with research into growth hormone release and gut movement. [1] [4]
Early work found a relatively selective GH-release response in the animal models tested. That is a description of experimental hormone measurements, not a promise that the compound has no effects on other hormones or no adverse effects in people. [1]
ENDOCRINE SIGNALLING
Examining the relationship between secretagogue exposure and growth hormone release.
GASTROINTESTINAL MOTILITY
Investigating how ghrelin-receptor stimulation influences movement through the digestive tract.
Main research areas
The strongest way to understand Ipamorelin is to separate the biological response being measured from the wider benefit sometimes claimed for it.
| Research area | What studies examine |
|---|---|
| GH release | Hormone secretion in rat pituitary-cell preparations and in rats and pigs. [1] |
| Human hormone response | The relationship between circulating Ipamorelin and GH concentrations in healthy male volunteers. [2] |
| Gut transit | Bowel movement and related outcomes in a rat model of postoperative ileus. [4] |
| Postsurgical gastrointestinal recovery | A placebo-controlled human trial measuring tolerance of a standardised solid meal after bowel surgery. [3] |
These research settings do not establish muscle gain, fat loss, better sleep or faster injury recovery from an Everform vial or pen.
What published findings show
Preclinical selectivity: Raun and colleagues reported GH release in rat pituitary cells and animal experiments. In pigs, ACTH and cortisol responses were not significantly different from those following GHRH stimulation under the tested conditions. These findings help describe pharmacology; they do not establish hormone neutrality in humans. [1]
Human pharmacology: Gobburu and colleagues measured Ipamorelin and GH in healthy male volunteers after controlled intravenous exposure. The study described an episode of GH release and modelled the exposure–response relationship. It did not test long-term strength, physique, sleep or recovery outcomes. Its findings should not be converted into an administration schedule for a research product. [2]
Animal gut-motility research: Venkova and colleagues reported changes in bowel transit and related measures in rats following abdominal surgery. This offered a basis for clinical investigation, rather than proof of benefit in people. [4]
Human gastrointestinal trial: Beck and colleagues enrolled 117 surgical patients, with 114 included in the safety and modified intention-to-treat populations. Median time to a first tolerated meal was 25.3 hours with Ipamorelin and 32.6 hours with placebo, but the difference was not statistically significant (p = 0.15). The key and secondary efficacy analyses did not show significant differences between groups. [3]
A measurable GH response and a demonstrated clinical benefit are different outcomes. The cited studies do not establish this Everform product as a treatment or as a means of improving body composition, sleep or athletic recovery.
The Everform product, at a glance
CompoundIpamorelin
Labelled vial amount10 mg
Base formatLyophilised peptide powder
Supply optionsSee the format guide above
Everform Pharma is based in Da Nang, Vietnam. This profile describes standalone Ipamorelin. Use the product options to select an available supply format. Complimentary BAC water is included with every order.
Explore Your format, your way →
The full REF on the product should match the relevant documentation. The security sticker repeats the product identifier and should match the vial or pen; it is not a separate new ID. Check the actual label for expiry and storage conditions.
Identity, chromatographic purity and measured peptide content answer different questions. A purity percentage alone does not establish the amount of peptide per vial or confirm every aspect of molecular identity.
Common questions
Is Ipamorelin growth hormone?
No. It is a secretagogue investigated for stimulating GH release, rather than the GH protein itself. [1]
What does “selective” mean in the early research?
It refers to the hormone responses observed in the tested models. The original animal findings do not justify a universal claim that Ipamorelin never affects cortisol or other hormones in people. [1]
Is this a combination with CJC 1295?
No. This page describes standalone Ipamorelin, labelled at 10 mg per vial.
Does 10 mg describe a dose?
No. It is the labelled amount of peptide in the vial, not a recommended dose or an administration instruction.
Does the human research prove muscle gain or better recovery?
No. The healthy-volunteer study measured pharmacology and GH release. The surgical trial examined gastrointestinal recovery. Neither establishes those performance outcomes. [2] [3]
How do I match the product to its documentation?
Use the full REF on the vial or pen. The package security sticker should repeat the same identifier. Follow the actual product label for storage and expiry information.
References
Everform Pharma · Da Nang, Vietnam
Educational product information.
For laboratory research only.
Not for human or veterinary use.
